atorvastatin has been researched along with Muscle Pain in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 17 (89.47) | 24.3611 |
2020's | 2 (10.53) | 2.80 |
Authors | Studies |
---|---|
Åsberg, A; Balligand, JL; Elens, L; Haufroid, V; Hoste, E; Muccioli, GG; Panin, N; Paquot, A; Stillemans, G | 1 |
Guidry, TJ; Jacobs, D; Sullivan, J; Wassell, K | 1 |
Christopher-Stine, L; Isackson, PJ; Kitzmiller, JP; Luzum, JA; Ma, C; Nguyen, LM; Ochs-Balcom, HM; Peltier, W; Tarnopolsky, M; Vladutiu, GD; Weisman, M; Wortmann, RL | 1 |
Ballard, KD; Capizzi, JA; Chipkin, S; Clarkson, PM; Cole, SM; Grimaldi, AS; Keadle, J; Parker, BA; Pescatello, LS; Simpson, K; Thompson, PD; White, CM | 1 |
Laaksonen, R | 1 |
Eleftheriadou, I; Grigoropoulou, P; Katsilambros, N; Makrilakis, K; Margeli, A; Papassotiriou, I; Perrea, D; Tentolouris, N; Zoupas, C | 1 |
Hegele, RA; Joy, TR; Mahon, JL; McDonald, CG; Monjed, A; Zou, GY | 1 |
Almeida, S; Ferreira, ME; Fiegenbaum, M; Hutz, MH; Lima, LO; Pires, RC; Smiderle, L; Van der Sand, CR; Van der Sand, LC | 1 |
Adamkova, V; Ceska, R; Hruba, P; Hubacek, JA; Vrablik, M | 1 |
Ballard, KD; Taylor, BA; Thompson, PD | 1 |
Adámková, V; Češka, R; Dlouhá, D; Hrubá, P; Hubáček, JA; Viklický, O; Vrablík, M; Zlatohlavek, L | 1 |
Nater, H; Perger, L; Suter, PM | 1 |
Ballantyne, CM; Brennan, DM; Bruckert, E; Ceška, R; Dent-Acosta, RE; Elliott, M; Gouni-Berthold, I; Lehman, SJ; Lepor, N; Nissen, SE; Preiss, D; Rosenson, RS; Sattar, N; Scott, R; Somaratne, R; Stein, EA; Stroes, E; Wasserman, SM | 1 |
Lv, H; Ren, H | 1 |
Ammendola, S; Loreto, MD; Scotto d'Abusco, A; Stoppoloni, D | 1 |
Bon, I; Borderi, M; Calza, L; Colangeli, V; Contadini, I; Magistrelli, E; Re, MC; Viale, P | 1 |
Sivaramakrishnan, G; Sridharan, K | 1 |
García-Estévez, DA; Navarro, C; San Millán, B; Sogo, T | 1 |
2 review(s) available for atorvastatin and Muscle Pain
Article | Year |
---|---|
[Help me--I do not tolerate my statin].
Topics: Aged; Aged, 80 and over; Atorvastatin; Diagnosis, Differential; Drug Substitution; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myalgia; Patient Education as Topic; Pyrroles; Quinolines; Risk Factors; Ubiquinone | 2015 |
Periodic dosing regimens of atorvastatin and rosuvastatin for dyslipidemia: A systematic review and meta-analysis of randomized controlled trials.
Topics: Atorvastatin; Child; Cholesterol, LDL; Drug Administration Schedule; Dyslipidemias; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myalgia; Randomized Controlled Trials as Topic; Rosuvastatin Calcium | 2017 |
5 trial(s) available for atorvastatin and Muscle Pain
Article | Year |
---|---|
Increases in creatine kinase with atorvastatin treatment are not associated with decreases in muscular performance.
Topics: Adult; Atorvastatin; Creatine Kinase; Double-Blind Method; Exercise; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Muscle Strength; Muscle, Skeletal; Muscles; Myalgia; Pyrroles; Treatment Outcome | 2013 |
Effect of atorvastatin on baroreflex sensitivity in subjects with type 2 diabetes and dyslipidaemia.
Topics: Aged; Atorvastatin; Baroreflex; Body Mass Index; Cardiovascular Agents; Cardiovascular Diseases; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Cardiomyopathies; Diet, Fat-Restricted; Dyslipidemias; Female; Greece; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myalgia; Obesity; Patient Dropouts; Prospective Studies; Pyrroles; Risk Factors | 2014 |
N-of-1 (single-patient) trials for statin-related myalgia.
Topics: Aged; Aged, 80 and over; Atorvastatin; Double-Blind Method; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Myalgia; Pyrimidines; Pyrroles; Research Design; Rosuvastatin Calcium; Sulfonamides | 2014 |
Statin-associated muscle injury.
Topics: Atorvastatin; Biomarkers; Creatine Kinase; Double-Blind Method; Healthy Volunteers; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Muscle, Skeletal; Myalgia; Risk Assessment; Risk Factors; Severity of Illness Index; Time Factors; Up-Regulation | 2015 |
Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticholesteremic Agents; Atorvastatin; Biomarkers; Cholesterol, LDL; Creatine Kinase; Cross-Over Studies; Double-Blind Method; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Muscular Diseases; Myalgia; Myositis; Rhabdomyolysis; Time Factors | 2016 |
12 other study(ies) available for atorvastatin and Muscle Pain
Article | Year |
---|---|
Atorvastatin population pharmacokinetics in a real-life setting: Influence of genetic polymorphisms and association with clinical response.
Topics: Atorvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver-Specific Organic Anion Transporter 1; Myalgia; Polymorphism, Single Nucleotide | 2022 |
Safety Outcomes of Atorvastatin 80 mg Versus Atorvastatin 40 mg in a Veteran Population.
Topics: Aged; Atorvastatin; Dose-Response Relationship, Drug; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Lipids; Male; Middle Aged; Muscle Weakness; Myalgia; Retrospective Studies; Veterans | 2020 |
Clinical features related to statin-associated muscle symptoms.
Topics: Aged; Atorvastatin; Female; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Logistic Models; Lovastatin; Male; Medical History Taking; Middle Aged; Muscle Weakness; Muscular Diseases; Myalgia; Obesity; Odds Ratio; Pravastatin; Retrospective Studies; Rhabdomyolysis; Risk Factors; Rosuvastatin Calcium; Simvastatin; Smoking; White People | 2019 |
STOMPing forward: statins, muscle complaints and CK.
Topics: Atherosclerosis; Atorvastatin; Creatine Kinase; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Muscle Weakness; Muscle, Skeletal; Muscles; Muscular Diseases; Myalgia; Pyrroles; Randomized Controlled Trials as Topic | 2013 |
Summaries for patients. Treatment trials to determine whether statins are the cause of a patient's discomfort.
Topics: Aged; Aged, 80 and over; Atorvastatin; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Myalgia; Pyrimidines; Pyrroles; Research Design; Rosuvastatin Calcium; Sulfonamides | 2014 |
Evaluation of sexual dimorphism in the efficacy and safety of simvastatin/atorvastatin therapy in a southern Brazilian cohort.
Topics: Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Atorvastatin; Brazil; Cholesterol; Creatine Kinase; Female; Heptanoic Acids; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Myalgia; Prospective Studies; Pyrroles; Sex Factors; Simvastatin | 2014 |
Association between polymorphism within the RYR2 receptor and development of statin-associated myalgia/myopathy in the Czech population.
Topics: Aged; Atorvastatin; Case-Control Studies; Czech Republic; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myalgia; Pilot Projects; Polymorphism, Genetic; Ryanodine Receptor Calcium Release Channel; Simvastatin; White People | 2015 |
SLCO1B1 polymorphism is not associated with risk of statin-induced myalgia/myopathy in a Czech population.
Topics: Aged; Atorvastatin; Czech Republic; Diabetes Mellitus; Dose-Response Relationship, Drug; Dyslipidemias; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Hepatocytes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver-Specific Organic Anion Transporter 1; Male; Middle Aged; Models, Genetic; Muscular Diseases; Myalgia; Obesity; Organic Anion Transporters; Polymorphism, Single Nucleotide; Simvastatin; Smoking | 2015 |
Neuromuscular Effects of Rocuronium Bromide in Patients in Statin Therapy for at least Three Months.
Topics: Aged; Androstanols; Anesthesia, General; Anesthesia, Intravenous; Atorvastatin; Biomarkers; China; Cohort Studies; Creatine Kinase; Drug Interactions; Drug Therapy, Combination; Elective Surgical Procedures; Hospitals, Teaching; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Middle Aged; Muscle, Skeletal; Myalgia; Neuromuscular Nondepolarizing Agents; Prospective Studies; Rocuronium; Severity of Illness Index | 2016 |
A Nutraceutical Composition Decreases CPK Levels in Saos-2 Cells and in Patients with Elevated Serum Levels of This Enzyme.
Topics: Adenosine Triphosphate; Adolescent; Adult; Aged; Atorvastatin; Cell Line; Cell Survival; Creatine Kinase; Dietary Supplements; Female; Gene Expression; Humans; L-Lactate Dehydrogenase; Male; Middle Aged; Myalgia; MyoD Protein; Osteoblasts; RNA, Messenger | 2016 |
Significant association between statin-associated myalgia and vitamin D deficiency among treated HIV-infected patients.
Topics: Adult; Aged; Anti-Retroviral Agents; Atorvastatin; Cardiovascular Diseases; Female; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myalgia; Retrospective Studies; Rosuvastatin Calcium; Vitamin D Deficiency | 2017 |
[Myopathy due to deficiency of desaminase myoadenilate induced by atorvastatine].
Topics: Aged; Amino Acid Substitution; AMP Deaminase; Atorvastatin; Biopsy; Causality; Creatine Kinase, MM Form; Exercise Tolerance; Female; Heptanoic Acids; Homozygote; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Liver-Specific Organic Anion Transporter 1; Mitochondria, Muscle; Models, Genetic; Muscle, Skeletal; Mutation, Missense; Myalgia; Organic Anion Transporters; Parkinsonian Disorders; Point Mutation; Polymorphism, Single Nucleotide; Purine-Pyrimidine Metabolism, Inborn Errors; Pyrroles; Ubiquinone | 2013 |